Cargando…

Trastuzumab treatment of invasive breast ductal carcinoma induces severe edema: a case report

BACKGROUND: Trastuzumab, a monoclonal antibody which binds to the extracellular domain of human epidermal growth factor receptor 2 (HER2), is the first biological drug approved for the treatment of HER2-positive breast cancer. However, trastuzumab exhibits a series of clinical adverse effects, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hua, Zheng, Jie, Wang, Qin, Ai, Yueqin, Zhao, Ying, Wang, Jing, Qu, Shuang, Hu, Jianhua, Jia, Shaochang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745366/ https://www.ncbi.nlm.nih.gov/pubmed/36523319 http://dx.doi.org/10.21037/tcr-22-1607

Ejemplares similares

Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma
por: Chen, Zheling, et al.
Publicado: (2017)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer
por: Shi, Sheng-Jia, et al.
Publicado: (2015)

Invasive ductal breast cancer metastatic to the sigmoid colon
por: Zhou, Xiao-cong, et al.
Publicado: (2012)

Focal breast edema and breast edema score on T2-weighted images provides valuable biological information for invasive breast cancer
por: Chen, Yanhong, et al.
Publicado: (2023)

Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis
por: Hao, Shuang, et al.
Publicado: (2019)

Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast
por: Li, Zhenling, et al.
Publicado: (2016)

Severe tinnitus and migraine headache in a 37-year-old woman treated with trastuzumab for breast cancer: A case report
por: Liu, Yong-Zhi, et al.
Publicado: (2022)

Maintenance Therapy with Trastuzumab in Her2 Positive Metastatic Parotid Ductal Adenocarcinoma
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2014)

Coexistence of invasive ductal breast carcinoma and fibroadenoma
por: Saadallah, Fatma, et al.
Publicado: (2019)

Educational Case: Invasive Ductal Carcinoma of the Breast
por: Scholl, Ashley Rose, et al.
Publicado: (2020)

PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast
por: Qian, Li, et al.
Publicado: (2017)

Expression of pAkt is associated with a poor prognosis in Chinese women with invasive ductal breast cancer
por: Zhou, Ling, et al.
Publicado: (2018)

Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal Carcinoma In Situ following Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature
por: Gunia, Sommer R., et al.
Publicado: (2012)

Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance
por: Sun, Hao-Ting, et al.
Publicado: (2015)

BAG3‐positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma
por: Yuan, Ye, et al.
Publicado: (2019)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
por: Lee, A. H., et al.
Publicado: (1996)

Expression of CD 133 in Invasive Ductal Carcinoma of Breast
por: Utnal, Preeti Ashok, et al.
Publicado: (2020)

Primary invasive ductal carcinoma of axillary accessory breast
por: Nguyen, Thi Hoa, et al.
Publicado: (2022)

Immunoarchitectural patterns as potential prognostic factors for invasive ductal breast cancer
por: Du, Xue, et al.
Publicado: (2022)

Trastuzumab deruxtecan for breast cancer
Publicado: (2022)

Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma
por: Li, Guanqiao, et al.
Publicado: (2016)

MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN
por: Ye, Xingming, et al.
Publicado: (2014)

Sharp Downregulation of Hub Genes Associated With the Pathogenesis of Breast Cancer From Ductal Carcinoma In Situ to Invasive Ductal Carcinoma
por: Wang, Yao, et al.
Publicado: (2021)

Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma
por: Lee, Jeeyeon, et al.
Publicado: (2020)

Association between obesity and trastuzumab-related cardiac toxicity in elderly patients with breast cancer
por: Wang, Hai-Yan, et al.
Publicado: (2017)

Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab
por: Thavendiranathan, Paaladinesh, et al.
Publicado: (2014)

Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Severe thrombocytopenia related to trastuzumab infusion
por: Mantzourani, Marina, et al.
Publicado: (2011)

The diagnostic value of contrast-enhanced ultrasonography in breast ductal abnormalities
por: Wang, Bo, et al.
Publicado: (2023)

Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma
por: He, Qiang, et al.
Publicado: (2021)

Prognostic model of invasive ductal carcinoma of the breast based on differentially expressed glycolysis-related genes
por: Li, Xiaoping, et al.
Publicado: (2020)

Trastuzumab Exposure in Early Pregnancy for a Young Lady With Locally Invasive Breast Cancer
por: Pianca, Natasha, et al.
Publicado: (2015)

Impact of 21-Gene Recurrence Score on Chemotherapy Decision in Invasive Ductal Carcinoma of Breast with Nodal Micrometastases
por: Chen, Wei-Rong, et al.
Publicado: (2019)

Identification of aberrant gene expression during breast ductal carcinoma in situ progression to invasive ductal carcinoma
por: Song, Guiqin, et al.
Publicado: (2019)

Triexponential Diffusion Analysis of Diffusion-weighted Imaging for Breast Ductal Carcinoma in Situ and Invasive Ductal Carcinoma
por: Ohno, Masako, et al.
Publicado: (2021)

Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
por: Liu, Yang, et al.
Publicado: (2023)

Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models
por: Veeraraghavan, Jamunarani, et al.
Publicado: (2021)

MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer
por: Johnson, Jennifer M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ng1jjgrfcd9bbuhuatlfaupmg1